Intravenous amiodarone (Q41459856)

1 October 2017

1 reference

title

Intravenous amiodarone (English)

1 reference

1 October 2017

1 reference

amiodarone

15 June 2024

Kowey PR

1 reference

1 October 2017

Marinchak RA

series ordinal

1 reference

1 October 2017

Rials SJ

series ordinal

1 reference

1 October 2017

Filart RA

series ordinal

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

Journal of the American College of Cardiology

1 October 2017

published in

1 reference

1 October 2017

1 reference

1 October 2017

1 reference

1 October 2017

page(s)

1190-1198

1 reference

Amiodarone: reevaluation of an old drug

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

1 reference

7 January 2021

Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT): rationale and protocol. CAMIAT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

The historical development, cellular electrophysiology and pharmacology of amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Amiodarone: Historical development and pharmacologic profile

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Pharmacokinetics of amiodarone after intravenous and oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Hypotensive Action of Commercial Intravenous Amiodarone and Polysorbate 80 in Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Electrophysiologic effects of Tween 80 in the myocardium and specialized conduction system of the canine heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Binding of amiodarone by serum proteins and the effects of drugs, hormones and other interacting ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Plasma protein binding of amiodarone in a patient population: measurement by erythrocyte partitioning and a novel glass-binding method

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Pharmacology and pharmacokinetics of amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Amiodarone pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Electropharmacology of amiodarone: absence of relationship to serum, myocardial, and cardiac sarcolemmal membrane drug concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Renal elimination of amiodarone and its desethyl metabolite

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Disposition of intravenous amiodarone in subjects with normal and impaired renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Amiodarone in patients on long-term dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Drug interactions with amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Effect of amiodarone on serum quinidine and procainamide levels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

The potentiation of warfarin anticoagulation by amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Amiodarone increases plasma digoxin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Sinus arrest and hypotension with combined amiodarone-diltiazem therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Effects of intravenous amiodarone in patients with inducible repetitive ventricular responses and ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Basic concepts in cellular cardiac electrophysiology: Part II: Block of ion channels by antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Pharmacokinetics and regional electrophysiological effects of intracoronary amiodarone administration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Electropharmacology of amiodarone therapy initiation. Time courses of onset of electrophysiologic and antiarrhythmic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Amiodarone: correlation of early and late electrophysiologic studies with outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Effects of acute intravenous and chronic oral amiodarone on defibrillation energy requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

The effect of chronic oral and acute intravenous amiodarone administration on ventricular defibrillation threshold using implanted electrodes in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Hemodynamic effects of intravenous amiodarone.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Efficacy of intravenous amiodarone as short-term treatment for refractory ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Intravenous amiodarone during prolonged resuscitation from cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Grou

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Intravenous amiodarone in ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Effects of amiodarone on sinus node in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Acute effects of amiodarone upon the canine sinus node and atrioventricular junctional region

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Amiodarone-induced torsades de pointes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

A general overview of amiodarone toxicity: its prevention, detection, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Amiodarone dosing: a proposal based on its pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Effects of amiodarone and desethylamiodarone on rabbit myocardial beta-adrenoceptors and serum thyroid hormones--absence of relationship to serum and myocardial drug concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

A comparative analysis of the loss of amiodarone from small and large volume PVC and non-PVC infusion systems

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

QT prolongation and the antiarrhythmic efficacy of amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Electrophysiologic testing in patients who respond acutely to intravenous amiodarone for incessant ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Intravenous amiodarone in the acute termination of supraventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Intravenous amiodarone in atrial fibrillation complicating myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

A comparison of amiodarone and digoxin for treatment of supraventricular arrhythmias after cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Oral amiodarone loading for the rapid treatment of frequent, refractory, sustained ventricular arrhythmias associated with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Rapid suppression of complex ventricular arrhythmias with high-dose oral amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Efficacy and safety of intravenous amiodarone for short-term treatment of paroxysmal supraventricular tachycardia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Clinical efficacy and safety of intravenous Amiodarone in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Amiodarone therapy during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Neonatal hypothyroidism after treatment by amiodarone during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Human experience with amiodarone in the embryonic period

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Amiodarone in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: Evidence for distinct mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Drug therapy: bretylium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Bretylium tosylate as initial treatment for cardiopulmonary arrest: randomized comparison with placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

Combination therapy for cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900069-7

7 January 2021

10.1016/S0735-1097(97)00069-7

Identifiers

DOI

1 reference

1 October 2017

1 reference